Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 42 companies including many key and niche players such as
- Abbott Laboratories, Inc. (US)
- Abbott Molecular, Inc. (US)
- Adaltis S.r.l. (Italy)
- Alere (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- Calypte Biomedical Corporation (US)
- Chembio Diagnostic Systems, Inc. (US)
- Hologic, Inc. (US)
- Fujirebio Europe N.V. (Belgium)
- MedMira Inc. (Canada)
- OraSure Technologies, Inc. (US)
- Ortho-Clinical Diagnostics, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare Diagnostics, Inc. (US)
- Trinity Biotech Plc. (Ireland)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. HIV/AIDS STATISTICS
4. HIV/AIDS: UNDERSTANDING THE DISEASE
5. DIAGNOSIS OF HIV/AIDS
6. PRODUCT APPROVALS & LAUNCHES
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
- The United States (33)
- Canada (2)
- Europe (8)
- - France (2)
- - Italy (2)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/cq3kt5/hivaids_testing
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infectious Disease Testing
